see all FSG blogs >
The Institute for OneWorld Health (IOWH) is a nonprofit pharmaceutical firm that develops safe, effective, and affordable new medicines for people with infectious diseases in the developing world. IOWH has registered its first drug in India for visceral leishmaniasis and has been expanding its portfolio of products to address other neglected diseases.
FSG helped the Institute for OneWorld Health develop a five-year diarrheal disease program strategy and access plan based on in-depth research in three countries.
FSG has also helped the Institute for OneWorld Health to:
Boston : Geneva : Mumbai : San Francisco : Seattle : Washington | 866.351.8484 | info@fsg.org
Follow Us: